Automated drug screening in ependymoma organoids identifies HDAC, anthracyclines, and proteasome inhibitors as potential therapeutic candidates
Use of biopsy-derived tumor organoids for personalized drug testing in recurrent glioblastoma
We use cookies on our website. Cookies are small (text) files that are created and stored on your device (e.g., smartphone, notebook, tablet, PC). Some of these cookies are technically necessary to operate the website, other cookies are used to extend the functionality of the website or for marketing purposes. Apart from the technically necessary cookies, you are free to allow or not allow cookies when visiting our website.